A detailed history of Us Financial Advisors, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Us Financial Advisors, LLC holds 7,815 shares of RPRX stock, worth $200,923. This represents 0.08% of its overall portfolio holdings.

Number of Shares
7,815
Previous 8,165 4.29%
Holding current value
$200,923
Previous $229,000 3.49%
% of portfolio
0.08%
Previous 0.09%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$27.46 - $31.33 $9,611 - $10,965
-350 Reduced 4.29%
7,815 $237,000
Q3 2023

Nov 09, 2023

SELL
$26.26 - $31.38 $270,057 - $322,711
-10,284 Reduced 55.74%
8,165 $221,000
Q2 2023

Aug 09, 2023

SELL
$29.6 - $36.56 $127,280 - $157,208
-4,300 Reduced 18.9%
18,449 $567,000
Q4 2022

Jan 26, 2023

BUY
$39.17 - $44.04 $891,078 - $1 Million
22,749 New
22,749 $0

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.2B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Us Financial Advisors, LLC Portfolio

Follow Us Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Us Financial Advisors, LLC with notifications on news.